Silo Pharma, Inc.
SILO
$0.39
$0.023.99%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | 0.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | 0.00% | |||
| Cost of Revenue | 0.00% | 0.00% | |||
| Gross Profit | 0.00% | 0.00% | |||
| SG&A Expenses | 21.09% | -21.03% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 100.43% | -31.20% | |||
| Operating Income | -102.76% | 31.70% | |||
| Income Before Tax | -86.85% | 20.61% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -86.85% | 20.61% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -86.85% | 20.61% | |||
| EBIT | -102.76% | 31.70% | |||
| EBITDA | -103.13% | 31.77% | |||
| EPS Basic | -82.25% | 44.62% | |||
| Normalized Basic EPS | -82.93% | 44.89% | |||
| EPS Diluted | -82.25% | 44.62% | |||
| Normalized Diluted EPS | -82.93% | 44.89% | |||
| Average Basic Shares Outstanding | 2.47% | 43.38% | |||
| Average Diluted Shares Outstanding | 2.47% | 43.38% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||